Stocktoria
Nurix Therapeutics, Inc. NRIX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-24
Nurix Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | 2026-06-25 | Sell | 5,394 | $20.00 |
| Ring Christine | Chief Legal Officer | 2026-06-25 | Option exercise | 13,333 | $7.26 |
| Ring Christine | Chief Legal Officer | 2026-06-25 | Option exercise | 15,602 | $8.72 |
| Ring Christine | Chief Legal Officer | 2026-06-25 | Sell | 28,935 | $20.06 |
| Ring Christine | Chief Legal Officer | 2026-06-02 | Option exercise | 3,422 | $1.86 |
| Ring Christine | Chief Legal Officer | 2026-06-02 | Sell | 8,148 | $16.60 |
Source: SEC EDGAR filings · CIK 0001549595 · as of 2025-11-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.